Form 4: OrthoPediatrics CEO David R. Bailey Reports Gift of 1,500 Shares

OrthoPediatrics Corp. CEO David R. Bailey reported a gift of 1,500 common stock shares, with no monetary transaction involved, on December 27, 2024.

Summary

• David R. Bailey, the President and CEO of OrthoPediatrics Corp., reported a transaction involving the company's common stock.
• On December 27, 2024, Mr. Bailey received 1,500 shares of common stock as a bona fide gift.
• The transaction did not involve any monetary exchange, with the price per share listed as $0.
• Following this transaction, Mr. Bailey's total direct holdings include 228,279 shares of common stock, which includes 149,930 shares of restricted stock awards.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock gift, with no positive or negative implications for the company's performance.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It does not indicate any significant change in the company's operations or outlook.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical reporting requirements.
• The gift of shares is not unusual for executive compensation and is often part of a broader incentive package.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a gift and does not dilute the stock.

Key Dates

Keywords

OrthoPediatrics, David R. Bailey, stock gift, common stock, insider transaction, SEC Form 4, restricted stock